HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report
Key Clinical Message HRAS mutations are frequent genetic alterations in epithelial‐myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-10-01
|
Series: | Clinical Case Reports |
Subjects: | |
Online Access: | https://doi.org/10.1002/ccr3.8099 |
_version_ | 1827784294417825792 |
---|---|
author | Taisei Yasuda Masami Osaki Masahiko Sugitani |
author_facet | Taisei Yasuda Masami Osaki Masahiko Sugitani |
author_sort | Taisei Yasuda |
collection | DOAJ |
description | Key Clinical Message HRAS mutations are frequent genetic alterations in epithelial‐myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib. |
first_indexed | 2024-03-11T15:59:57Z |
format | Article |
id | doaj.art-7f9bc0e80562459088c9fe653ad3e4e3 |
institution | Directory Open Access Journal |
issn | 2050-0904 |
language | English |
last_indexed | 2024-03-11T15:59:57Z |
publishDate | 2023-10-01 |
publisher | Wiley |
record_format | Article |
series | Clinical Case Reports |
spelling | doaj.art-7f9bc0e80562459088c9fe653ad3e4e32023-10-25T07:12:45ZengWileyClinical Case Reports2050-09042023-10-011110n/an/a10.1002/ccr3.8099HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case reportTaisei Yasuda0Masami Osaki1Masahiko Sugitani2Department of Otolaryngology‐Head and Neck Surgery Ageo Central General Hospital Saitama JapanDepartment of Otolaryngology‐Head and Neck Surgery Ageo Central General Hospital Saitama JapanDepartment of Pathology Ageo Central General Hospital Saitama JapanKey Clinical Message HRAS mutations are frequent genetic alterations in epithelial‐myoepithelial carcinoma, and they may be useful as ancillary molecular tests and predictive molecular tests for targeted therapy with tipifarnib.https://doi.org/10.1002/ccr3.8099epithelial‐myoepithelial carcinomaHRAS mutationsalivary gland carcinoma |
spellingShingle | Taisei Yasuda Masami Osaki Masahiko Sugitani HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report Clinical Case Reports epithelial‐myoepithelial carcinoma HRAS mutation salivary gland carcinoma |
title | HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report |
title_full | HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report |
title_fullStr | HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report |
title_full_unstemmed | HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report |
title_short | HRAS mutation as a diagnostic molecular analysis for epithelial‐myoepithelial carcinoma of the parotid gland: A case report |
title_sort | hras mutation as a diagnostic molecular analysis for epithelial myoepithelial carcinoma of the parotid gland a case report |
topic | epithelial‐myoepithelial carcinoma HRAS mutation salivary gland carcinoma |
url | https://doi.org/10.1002/ccr3.8099 |
work_keys_str_mv | AT taiseiyasuda hrasmutationasadiagnosticmolecularanalysisforepithelialmyoepithelialcarcinomaoftheparotidglandacasereport AT masamiosaki hrasmutationasadiagnosticmolecularanalysisforepithelialmyoepithelialcarcinomaoftheparotidglandacasereport AT masahikosugitani hrasmutationasadiagnosticmolecularanalysisforepithelialmyoepithelialcarcinomaoftheparotidglandacasereport |